Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial (Q40075275)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial |
scientific article |
Statements
1 reference
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial (English)
1 reference
Feng-Cai Zhu
1 reference
Alie H Wurie
1 reference
Li-Hua Hou
1 reference
Qi Liang
1 reference
Yu-Hua Li
1 reference
James B W Russell
1 reference
Shi-Po Wu
1 reference
Jing-Xin Li
1 reference
Yue-Mei Hu
1 reference
Qiang Guo
1 reference
Wen-Bo Xu
1 reference
Abdul R Wurie
1 reference
Wen-Juan Wang
1 reference
Zhe Zhang
1 reference
Wen-Jiao Yin
1 reference
Manal Ghazzawi
1 reference
Xu Zhang
1 reference
Lei Duan
1 reference
Jun-Zhi Wang
1 reference
Wei Chen
1 reference
22 December 2016
1 reference
1 reference
389
1 reference
10069
1 reference
621-628
1 reference
Identifiers
1 reference
1 reference